Anti‐Inflammatory and Anti‐Osteoclastogenesis Activities of Different Kinds of Zanthoxylum bungeanum Seed Oil in Vitro

Author:

Zhang Baochao12,Luo Shuhan12,Wu Shanshan12,Li Jingjing3,He Fangting4,Luo Ruocheng12,Wu Yating12,Pan Meiling12,Yong Li5,Pei Xiaofang126ORCID

Affiliation:

1. West China School of Public Health and West China Fourth Hospital Sichuan University Renmin South Road Chengdu 610041 China

2. Food Safety Monitoring and Risk Assessment Key Laboratory of Sichuan Province Department of Public Health Laboratory Sciences West China School of Public Health Sichuan University Renmin South Road Chengdu 610041 China

3. Department of Healthcare-associated Infection Management The Affiliated Hospital of Guizhou Medical University Guiyi Road Guiyang 550004 China

4. Department of Laboratory Medicine Chengdu Second People's Hospital Qingyun South Road Chengdu 610041 China

5. Sichuan Center for Disease Control and Prevention Zhongxue Road Chengdu 610041 China

6. West China-PUMC C. C. Chen Institute of Health Sichuan University Chengdu 610041 China

Abstract

AbstractOur previous study has exhibited that one kind of Zanthoxylum bungeanum seed oil (ZSO), extracted from Zanthoxylum bungeanum seed, had inhibitory effects on osteoclastogenesis. However, the anti‐osteoclastogenesis activities of different kinds of ZSO are scarcely reported. Since inflammation is related to bone loss and osteoporosis, in this study, three kinds of ZSO, Zanthoxylum schinifolium Siebold et Zucc seed oil (ZSSO), Zanthoxylum armatum DC. seed oil (ZDSO) and Zanthoxylum bungeanum maximum seed oil (ZBSO), were obtained with Soxhlet extraction and their fatty acid constituents were detected by GC‐FID. RAW264.7 macrophages induced by lipopolysaccharide (LPS) were used to evaluate the inhibitory effects of three kinds of ZSO on inflammation via detecting the expression levels of inflammatory factors by RT‐qPCR. Moreover, RANKL‐induced osteoclastogenesis was applied to demonstrate the anti‐osteoclastogenesis activities of them through tartrate‐resistant acid phosphatase (TRAP) staining and RT‐qPCR. The GC‐FID results exhibited that the highest constituent in ZSSO and ZDSO was oleic acid (OA) and palmitoleic acid (PLA), respectively. While linoleic acid (LA) and α‐Linolenic acid (ALA) in ZBSO were dominant. At the concentration of 0.5 μL/mL, all three kinds of ZSO could decrease the expression levels of inducible NO synthase (iNOS), cyclooxygenase‐2 (COX‐2), tumor necrosis factor‐α (TNF‐α), interleukin‐6 (IL‐6), interleukin‐1 beta (IL‐1β) in LPS‐induced macrophages. At the concentration of 0.25 μL/mL, only ZSSO could decrease the expression levels of iNOS and COX‐2, which implied the inhibitory effects of ZSSO were stronger than other ZSOs. The number of RANKL‐induced osteoclasts and the expressions of nuclear factor kappa‐B (NF‐κB), TNF‐α and IL‐6 in the cells were decreased after being treated with ZSOs at the concentration of 0.5 μL/mL, while the number of RANKL‐induced osteoclasts after treated with ZBSO were less than those treated with other ZSOs, this indicated that the anti‐osteoclastogenesis effect of ZBSO were stronger than other ZSOs. In conclusion, the fatty acid compositions of three major kinds of ZSO were compared and the content of unsaturated fatty acids especially ω‐3 polyunsaturated fatty acids in ZBSO were the highest among them. All ZSOs tested had anti‐inflammatory and anti‐osteoclastogenesis activities. And their anti‐osteoclastogenesis effects might be related to the suppression of the NF‐κB pathway.

Publisher

Wiley

Subject

Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3